Sobre la Empresa
- Nombre legal: Bioworkshops
- País de registro: China
- Dirección: No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou
- Número de empleados: 100 - 249
Descripción:
A full-service CDMO for antibody products, Bioworkshops offers development and cGMP manufacturing of drug substance and final product, including cell line development, process development, analytical methods, formulation, and process characterization/validation, with 13,000 liters of single-use cell culture capacity (200L to 2000L), three aseptic filling lines for vials, lyophilized products and prefilled syringes/cartridges up to 100,000 units per batch, along with product testing and CTD dossier support.
Actividades Comerciales
Productos Biofarmacéuticos
Fabricante por Contrato (CMO)Empresa en etapa inicial (start-up)
Clasificación ATC (Anatómica, Terapéutica, Química)
Fabricante por Contrato (CMO)Empresa en etapa inicial (start-up)
IFA de Marca Original
Fabricante por Contrato (CMO)Empresa en etapa inicial (start-up)
Productos/Servicios Clave
- Productos Biofarmacéuticos: Trastuzumab emtansine, Trastuzumab deruxtecan, Bedinvetmab, Benralizumab, Bevacizumab, Burosumab, Camrelizumab, Canakinumab, Casirivimab, Cetuximab, Cilgavimab, Daratumumab, Denosumab, Disitamab Vedotin, Dostarlimab, Dulaglutide, Dupilumab, Durvalumab, Eculizumab, Emicizumab, Erenumab, Etesevimab, Evolocumab, Faricimab, Fremanezumab, Frunevetmab, Galcanezumab, Guselkumab, Hyaluronidase Recombinant Human, Imdevimab, Lanadelumab, Lecanemab, Lokivetmab, Mepolizumab, Nirsevimab, Nivolumab, Ocrelizumab, Ofatumumab, Omalizumab, Palivizumab, Panitumumab, Pembrolizumab, Pertuzumab, Polatuzumab, Ramucirumab, Ranibizumab, Ravulizumab, Recombinant Zoster Vaccine, Risankizumab, Rituximab, Romiplostim, Romosozumab, Sarilumab, Sotatercept-csrk, Tezepelumab, Theralizumab, Tixagevimab & Cilgavimab, Tocilizumab, Trastuzumab, Ustekinumab, Adalimumab, Anifrolumab, Atezolizumab, Bamlanivimab, Bebtelovimab
- Servicios Biofarmacéuticos: Cell Line Development, GMP manufacturing for cell culture products
- Clasificación ATC (Anatómica, Terapéutica, Química): Respiratory Syncytial Virus Vaccine
Nuestros Productos & Servicios
Sell · Biopharmaceutical Products
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario